enVVeno Medical Corp Lessee, Operating Lease, Liability, to be Paid, Year One
enVVeno Medical Corp (NVNO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $411.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-26
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $411.00K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $399.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $387.00K.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $376.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $411.00K 10-K · filed 2026-03-26 |
| 2024-12-31 | $399.00K 10-K · filed 2025-02-28 |
| 2023-12-31 | $387.00K 10-K · filed 2024-02-29 |
| 2022-12-31 | $376.00K 10-K · filed 2023-03-02 |
| 2021-12-31 | $365.19K 10-K · filed 2022-03-28 |
| 2021-09-30 | $271.85K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $271.85K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $271.85K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $354.56K 10-K · filed 2021-03-31 |
| 2020-09-30 | $354.56K 10-Q · filed 2020-11-17 |
| 2020-06-30 | $354.56K 10-Q · filed 2020-08-14 |
| 2019-12-31 | $344.23K 10-K · filed 2020-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |